Skinbiotherapeutics (LON:SBTX) Issues Quarterly Earnings Results

Skinbiotherapeutics (LON:SBTX) issued its quarterly earnings data on Tuesday. The company reported GBX (0.94) (($0.01)) EPS for the quarter, Digital Look Earnings reports.

Shares of Skinbiotherapeutics stock opened at GBX 15.44 ($0.20) on Thursday. Skinbiotherapeutics has a 12 month low of GBX 12 ($0.16) and a 12 month high of GBX 26 ($0.34). The company has a market capitalization of $19.78 million and a PE ratio of -17.16. The stock’s fifty day simple moving average is GBX 17.50 and its 200 day simple moving average is GBX 18.51.

About Skinbiotherapeutics

SkinBioTherapeutics plc, a life science company, engages in the research and development of lysates derived from the human microbiome on skin. It is developing pre-clinical product application, SkinBiotix, a cosmetic cream for skin health, as well as for applications in infection control and eczema. The company was formerly known as Skinbiotix Ltd.

Featured Article: Compound Interest

Receive News & Ratings for Skinbiotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skinbiotherapeutics and related companies with's FREE daily email newsletter.